IL11 and gastric neoplasm: Gastric tumors in the Gp130FF model are driven by IL-11 signalling, which we have documented previously through genetic ablation of the ligand-binding IL-11RA receptor subunit, or following therapeutic administration of the IL-11 antagonist IL-11-mutein (21).